This ticker has not been starred yet PTGX Protagonist Therapeutics, Inc
Pharmaceutical Preparations
Book value per $ invested $ 0.13
Leverage 8.02%
Market Cap $ 4.8B
PE 107.62
Dividend Yield 0.00%
Profit $ 44.6m
Margin 21.47%

Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.

Subscribe Now For Access - Only $1.99 Per Month